<DOC>
	<DOCNO>NCT02396251</DOCNO>
	<brief_summary>A multi-centre , evaluator-blinded study subject undergo cheek augmentation . The study design assess efficacy regard aesthetic midface augmentation safety treatment HA product .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Hyaluronic Acid ( HA ) Product Cheek Augmentation</brief_title>
	<detailed_description />
	<criteria>Provide sign date informed consent participate study include release copyright image Man woman age 18 year old Be willing abstain facial plastic surgical cosmetic procedure close proximity treat area Known/previous allergy hypersensitivity injectable HA gel History bleed disorder treatment anticoagulant , thrombolytic , inhibitor platelet aggregation , omega3 , vitamin E within 2 week treatment Treatment chemotherapy , immunosuppressive agent , immunomodulatory therapy , topical retinoids , systemic topical corticosteroid within 3 month treatment systemic retinoids within 6 month treatment Previous tissue augment therapy contour permanent filler , fatinjection permanent implant place area treat The subject , opinion investigator , unlikely comply clinical investigational plan unsuitable reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>